肝衰竭患者预后预测研究进展*

doi:10.3969/j.issn.1672-5069.2023.04.039

实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (4): 605-608.doi: 10.3969/j.issn.1672-5069.2023.04.039

• 综述 • 上一篇

肝衰竭患者预后预测研究进展^*

李顶春综述, 游晶, 李武审校

650032 昆明市昆明医科大学第一附属医院感染性疾病科

收稿日期:2022-01-18 出版日期:2023-07-10 发布日期:2023-07-21
通讯作者: 游晶,E-mail: jingyoukm@126.com
作者简介:李顶春,女,28岁,博士研究生,医师。研究方向:肝衰竭防治。E-mail:449113045@qq.com
基金资助:
^*国家自然科学基金资助项目(编号:81760111/81760617);国家科技重大专项课题SEARCH-B研究项目(编号:2012ZX10002003);云南省科技厅－昆明医科大学联合基金重点科研项目[编号:2017FE468(-173)]; 云南省“万人计划”名医专项[编号:云人卫发(2020)20号,RLMY20200015]

Prognosis of patients with liver failure

Li Dingchun, You Jing, Li Wu

Department of Infectious Diseases and Liver Diseases, First Affiliated Hospital, Kunming Medical University, Kunming 650032, Yunnan Province, China

Received:2022-01-18 Online:2023-07-10 Published:2023-07-21

摘要/Abstract

摘要： 目的肝衰竭是由各种因素导致的肝脏合成、解毒、代谢和生物转化等功能的严重损害。肝衰竭病因多样,预后极差,病死率极高。如何客观地评估肝衰竭的严重程度,提供适时的治疗方案非常重要。肝衰竭发病机制复杂,病情进展快,影响预后因素多,目前对肝衰竭患者预后研究成为一大热点。除了临床上应用较多的MELD评分、CTP评分、SOFA评分等外,许多肝衰竭预后评价体系和新的预后标记物被发现和挖掘。本文对肝衰竭预后评估的模型和评分进行了综述和介绍。

关键词: 肝衰竭, 预后, 模型, 评分

Abstract: Objective Liver failure (LF) is a serious syndrome with liver function, such as synthesis, detoxification, metabolism and biotransformation damages, caused by various factors. The causes of LF are diverse, the prognosis is extremely poor, and the mortality rate is extremely high. How to evaluate the severity of liver failure objectively and provide a timely and appropriate treatment plan for patients with LF is very important. The pathogenesis of LF is complicated, the disease progresses rapidly, and there are many factors affecting its prognosis. At present, the research on the prognosis has become a hot spot. In addition to the MELD score, CTP score, SOFA score, etc., many prognostic evaluation systems and new prognostic markers have been discovered. In this article, we provide a review of models and scores for prognostic evaluation of patients with LF.

Key words: Liver failure, Prognosis, Model, Score

李顶春, 游晶, 李武. 肝衰竭患者预后预测研究进展^*[J]. 实用肝脏病杂志, 2023, 26(4): 605-608.

Li Dingchun, You Jing, Li Wu. Prognosis of patients with liver failure[J]. Journal of Practical Hepatology, 2023, 26(4): 605-608.

参考文献

[1] Zhang J,Luo H, Han Y, et al. Sequential versus mono double plasma molecular adsorption system in acute-on-chronic liver failures: A propensity-score matched study. Int J Artif Organs, 2022,45(1):5-13.
[2] Child CG, Turcotte JG. Surgery and portal hypertension. Major Prob Clin Surg, 1964, 1:1-85.
[3] Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973,60(8):646-649.
[4] 陈铿,曹欣,郑茵,等. MELD-Na与CTP评分评估乙型肝炎慢加急性肝衰竭短期预后的对比研究. 中华肝脏病杂志,2014,22(11):801-805.
[5] O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 1989,97(2):439-445.
[6] Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol, 1997,26(1):62-68.
[7] McPhail MJ, Farne H, Senvar N, et al. Ability of king's college criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol, 2016,14(4):516-525.e5,quiz e43-e45.
[8] Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Inten Care Med, 1996,22(7):707-710.
[9] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (Baltimore, Md), 2000,31(4):864-871.
[10] Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md), 2001,33(2):464-470.
[11] Lee HS, Choi GH, Joo DJ, et al. Prognostic value of model for end-stage liver disease scores in patients with fulminant hepatic failure. Transplant Proc, 2013,45(8):2992-2994.
[12] Zheng YX, Zhong X, Li YJ, et al. Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis. J Gastroenterol Hepatol, 2017,32(10):1668-1678.
[13] Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology, 2006,130(6):1652-1660.
[14] Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl, 2007,13(8):1174-1180.
[15] 李晨,游绍莉,刘鸿凌,等. 基线MELD、MELD-Na、iMELD 3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值. 中华危重病急救医学,2014,26(8):539-543.
[16] Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol, 2014,61(5):1038-1047.
[17] Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut, 2018,67(12):2181-2191.
[18] Tong JJ, Zhao W, Mu XY, et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl), 2019,132(13):1541-1549.
[19] Choudhury A, Jindal A, Maiwall R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int, 2017,11(5):461-471.
[20] Dal Moro F, Abate A, Lanckriet GR, et al. A novel approach for accurate prediction of spontaneous passage of ureteral stones: support vector machines. Kidney Int, 2006, 69(1):157-160.
[21] Hou Y, Zhang Q, Gao F, et al. Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC gastroenterol, 2020,20(1):75.
[22] Qin G, Bian ZL, Shen Y, et al. Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis. BMC Med Inform Decis Mak, 2016,16:59.
[23] Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl, 2005,11(3):336-343.
[24] Chen RC, Wang XD, Dong JZ, et al. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clin Chim Acta, 2017,468:195-200.
[25] Gong J, Zhou W, Xiao C, et al. A nomogram for predicting prognostic value of inflammatory biomarkers in patients with acute-on-chronic liver failure. Clin Chim Acta, 2018,478:7-12.
[26] 周超,宫嫚,张宁,等. 列线图预测乙型肝炎病毒相关慢加急性肝衰竭死亡风险的临床研究. 中西医结合肝病杂志,2021,31(2):102-107.

肝衰竭患者预后预测研究进展^*

Prognosis of patients with liver failure

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	仁增卓嘎, 王志鑫, 尹凤娇, 王海久. 抗菌肽抑制Caspase-3表达对内毒素诱导的急性肝衰竭小鼠肝细胞凋亡的影响^*[J]. 实用肝脏病杂志, 2023, 26(4): 472-475.
[2]	张亦瑾, 高学松, 高丽丽, 郝一炜, 段雪飞. 儿童与成人肝豆状核变性患者临床特征和生存分析^*[J]. 实用肝脏病杂志, 2023, 26(4): 520-523.
[3]	焦宇兵, 李灵, 黄新辉, 谢义星, 吴为敏, 翁吓俤, 郭武华. 核苷(酸)类似物抗病毒治疗HBV相关肝细胞癌患者低病毒血症及其对肿瘤治疗疗效的影响^*[J]. 实用肝脏病杂志, 2023, 26(4): 548-551.
[4]	陈钰, 陈斌斌, 赵静, 吴彬彬. MRI联合血清AFP-L3和VEGF水平预测TACE术治疗的原发性肝癌患者预后的价值^*[J]. 实用肝脏病杂志, 2023, 26(4): 556-559.
[5]	周盈营, 赵斌, 信学礼, 刘亚彬. 胆道闭锁小儿肝组织MMP-2和TGF-β1表达及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(4): 588-591.
[6]	徐林芳. 食管胃底静脉曲张破裂出血患者血清PGE2和IL-6水平及PALBI评分变化及其临床意义探讨[J]. 实用肝脏病杂志, 2023, 26(4): 596-598.
[7]	张丹眉, 石春霞, 陈倩, 张璐懿, 张清奇, 邹旭晨, 龚作炯. 糖原合酶激酶3β抑制剂TDZD-8对急性肝衰竭小鼠肝组织炎症的保护作用研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 324-327.
[8]	石磊, 安梓铭, 冯琴. 联合检测血清AFP、AFP-L3%和PIVKA-II水平早期诊断和判断原发性肝癌患者预后临床价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(3): 404-407.
[9]	邓珂欣, 罗红春. 常用血液学指标评定慢加急性肝衰竭患者并发细菌感染和预后价值研究^*[J]. 实用肝脏病杂志, 2023, 26(2): 242-245.
[10]	程晓燕, 赵爱明, 李海丹, 万艳红, 庞慧贤. 慢加急性乙型肝炎肝衰竭患者医院感染病原菌分布及血清Th1/Th2型细胞因子水平变化^*[J]. 实用肝脏病杂志, 2023, 26(2): 246-249.
[11]	陆金帅, 游道峰, 李楠. 慢加急性乙型肝炎肝衰竭患者外周血单个核细胞IP-10和COX-2水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(2): 250-253.
[12]	刘海霞, 朱云霞, 段忠辉, 赖曼, 陈煜. 近20年妊娠急性脂肪肝患者预后变化和死亡原因分析[J]. 实用肝脏病杂志, 2023, 26(1): 55-58.
[13]	吴成勇, 陈冲, 刘文艳, 唐光敏. 慢加急性乙型肝炎肝衰竭患者并发细菌感染及其预测模型效能评价^*[J]. 实用肝脏病杂志, 2023, 26(1): 59-62.
[14]	邵思萌, 高峰, 蒋磊, 魏亚虎, 赵威. 慢加急性乙型肝炎肝衰竭患者外周血巨噬细胞极化和TXNIP/NLRP3水平与预后的关系探讨^*[J]. 实用肝脏病杂志, 2023, 26(1): 63-66.
[15]	祝欣雯, 王卫兵, 袁福兵, 吴鑫. NLR联合血清IL-6水平预测慢加急性乙型肝炎肝衰竭患者近期预后的价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(1): 67-70.